ZyVersa Therapeutics, Inc.
ZVSA
$0.6794
-$0.0306-4.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.76% | -51.21% | -92.22% | -47.75% | 59.11% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -42.44% | -14.20% | -37.28% | -41.15% | -34.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -27.23% | -48.83% | -80.53% | -42.51% | 2.31% |
|
|
|||||
| Total Current Assets | -27.23% | -48.83% | -80.53% | -42.51% | 2.31% |
| Net Property, Plant & Equipment | -- | -100.00% | -- | -97.42% | -95.28% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | -39.47% | -39.47% | -81.37% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 130.76% | 139.29% | -- | -- | 110.92% |
| Total Assets | -3.07% | -6.85% | -40.87% | -39.13% | -81.17% |
|
|
|||||
| Total Accounts Payable | 18.17% | 10.74% | 4.35% | 2.12% | 27.37% |
| Total Accrued Expenses | 65.21% | 51.27% | 5.21% | 2.45% | 30.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 0.00% | -98.56% | -98.85% | -98.88% | -99.27% |
| Total Other Current Liabilities | 0.00% | -98.56% | -98.85% | -98.88% | -99.27% |
| Total Current Liabilities | 25.26% | 10.17% | -1.41% | -4.67% | 11.71% |
|
|
|||||
| Total Current Liabilities | 25.26% | 10.17% | -1.41% | -4.67% | 11.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.80% | 0.80% | -40.69% | -40.71% | -90.89% |
| Total Liabilities | 23.28% | 9.45% | -5.72% | -9.03% | -41.60% |
|
|
|||||
| Common Stock & APIC | 4.90% | 6.00% | 7.90% | 9.71% | 11.10% |
| Retained Earnings | -8.34% | -9.12% | -23.73% | -25.10% | -1,152.74% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Common Equity | -27.56% | -23.10% | -64.34% | -57.03% | -88.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.56% | -23.10% | -64.34% | -57.03% | -88.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.56% | -23.10% | -64.34% | -57.03% | -88.44% |
|
|
|||||